Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase I
22nd Annual Susan G. Komen Phoenix Race For The CureĀ® 2014 Moves To Downtown Phoenix 8/20/2014 9:35:19 AM
KalVista Pharmaceuticals Announces Start Of Clinical Development For Novel Treatment For Diabetic Macular Edema 8/20/2014 7:50:51 AM
NuSirt Biopharma Launches First Clinical Trial 8/20/2014 10:15:56 AM
Oncothyreon Inc. (ONTY)'s Lung Cancer Drug EMR 63325-009 Misses Primary Endpoint In Phase 1 Study 8/20/2014 6:12:35 AM
DelMar Pharmaceuticals Provides Update On Glioblastoma Clinical Trial And Results Of Warrant Tender Offer 8/19/2014 7:45:29 AM
Anavex Life Sciences Corp. (AVXL.OB) Reports That Antidepressant Fluvoxamine Reduces Stress Through Sigma-1 Receptor 8/19/2014 7:24:15 AM
Data Published By Researchers From The Scripps Research Institute Demonstrate Potential For MYC Inhibitor Licensed By Sorrento Therapeutics, Inc. 8/18/2014 9:08:21 AM
MonoSolRx LLC Launches Clinical Study Of MSRX-110 Oral Film For Testosterone Replacement 8/18/2014 7:07:40 AM
TG Therapeutics, Inc. (MHA) Announces Novel "Chemo-Free" Triple Therapy Combination Clinical Study For Patients With Chronic Lymphocytic Leukemia And Other B-Cell Malignancies 8/15/2014 7:53:00 AM
Tekmira Pharmaceuticals Corporation (TKMR)'s Experimental Ebola Drug May Never Reach Africa 8/14/2014 6:41:34 AM
Publication By KaloBios Pharmaceuticals, Inc. (KBIO) And Collaborators Shows EphA3 As Target For Highly Selective Anticancer Therapy 8/14/2014 9:09:47 AM
Alexza Pharmaceuticals, Inc. (ALXA) Provides An Update On The Five Post-EMA Approval Studies For ADASUVEĀ® 8/14/2014 8:05:48 AM
Nuvilex (NVLX) Announces Publication Of Combined Results Of The Initial Phase 1/2 Clinical Trial And A Second Phase 2 Clinical Trial Of The Cell-In-A-Box® Plus Ifosfamide Combination In Patients With Advanced, Inoperable Pancreatic Cancer 8/14/2014 7:45:24 AM
Epizyme (EPZM) Presents Pre-Clinical Data And Early Clinical Observations From Ongoing Phase 1 Trial Of EZH2 Inhibitor EPZ-6438 (E7438) At American Society of Hematology Meeting On Lymphoma Biology 8/13/2014 7:46:51 AM
Agios Pharmaceuticals (AGIO) Announces The U.S. FDA Grants Fast Track Designation To AG-221 For Treatment Of Patients With Acute Myelogenous Leukemia That Harbor An IDH2 Mutation 8/13/2014 7:27:33 AM
1234567
//-->